Print
18 February 2015
PharmExecutive
With a population of 420 million generating $4660 billion in GDP, Eastern Europe is swiftly gaining momentum as a key area for private and public investment in healthcare and health services, according to a new Frost & Sullivan Insights report.
Eastern Europe Healthcare Outlook 2014 points to “booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS”, shedding light on the changing healthcare dynamics in the region. With the number of hospitals reaching nearly 15.000 units, healthcare spending has been growing from $260 billion of 2010 to an additional 13 per cent in 2013. The percentage of private healthcare spending has also seen growth of an additional 6 per cent from 44 per cent of 2010.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.